Shu‐Fang Cheng

614 citations
33 papers · 536 indexed · h-index 14
Topics
HIV Research and Treatment (11 papers)Protein Structure and Dynamics (11 papers)Lipid Membrane Structure and Behavior (10 papers)
Partner nations
TaiwanSingaporeChina

In The Last Decade

Shu‐Fang Cheng

30 papers receiving 530 citations

Peers

Shu‐Fang Cheng
Comparison fields: 5 of 60
  • Molecular Biology 366
  • Virology 164
  • Epidemiology 163
  • Infectious Diseases 77
  • Radiology, Nuclear Medicine and Imaging 58
Replace Paolo Di Giovine with:
Paolo Di Giovine Italy
Yossef Kliger Israel
Berea A. R. Williams United States
Kelly Sackett Israel
Beatriz Apellániz Spain
Andreas Hinz Germany
Nerea Huarte Spain
Mark S. Drinker United States
Alexander Litovchick Israel
Hong Ji United States
Shu‐Fang Cheng relative to Paolo Di Giovine Italy Paolo Di Giovine's profile →
Citations per field
00.5×1.5×1.8×
Paolo Di Giovine · 1×
Citations per year

Countries citing papers authored by Shu‐Fang Cheng

Since Specialization
Citations

This map shows the geographic impact of Shu‐Fang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Fang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Fang Cheng more than expected).

Fields of papers citing papers by Shu‐Fang Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Fang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Fang Cheng. The network helps show where Shu‐Fang Cheng may publish in the future.

Co-authorship network of co-authors of Shu‐Fang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Fang Cheng. A scholar is included among the top collaborators of Shu‐Fang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Fang Cheng. Shu‐Fang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 4
6 8
7 57
8 7
9 16
10 10
11 37
12 20
13 13
14 10
15 42
16 6
17 48
18 12
19 3
20 18

About Shu‐Fang Cheng

Shu‐Fang Cheng is a scholar working on Virology, Microbiology and Molecular Biology, having authored 33 papers that have together received 536 indexed citations. Recurring topics across this work include HIV Research and Treatment (11 papers), Protein Structure and Dynamics (11 papers) and Lipid Membrane Structure and Behavior (10 papers). The work is most often cited by research in Virology (164 citations), Molecular Biology (366 citations) and Microbiology (32 citations). Shu‐Fang Cheng has collaborated with scholars based in Taiwan, Singapore and China. Frequent co-authors include Ding‐Kwo Chang, Vishwa D. Trivedi, D. K. Chang, Chengwei Wu, Eric Assen B. Kantchev, Annie‐Claude Roche, Chengwei Wu, Wen‐guey Wu, Cheng‐Wei Wu and Weining Huang. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026